A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia

American Journal of Surgical Pathology

Volumn 40, Issue 1, 2016, Pages 14-26

  Carr, Norman J ^a,b,c   Cecil, Thomas D ^a,b   Mohamed, Faheez ^a,b   Sobin, Leslie H ^d   Sugarbaker, Paul H ^e   González Moreno, Santiago ^f   Taflampas, Panos ^a,b   Chapman, Sara ^c   Moran, Brendan J ^a,b  

^a Peritoneal Malignancy Institute   (United Kingdom)

^b NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

^e WASHINGTON CANCER INSTITUTE   (United States)

^f MD ANDERSON CANCER CENTER   (Spain)

Author keywords

appendiceal neoplasms; appendix; Delphi technique; peritoneum; pseudomyxoma peritonei

Indexed keywords

MUCIN; TUMOR MARKER;

APPENDIX TUMOR; BIOPSY; CANCER GRADING; CHECKLIST; CHEMISTRY; CLASSIFICATION; CONSENSUS; CONSENSUS DEVELOPMENT; DELPHI STUDY; HUMAN; LYMPH NODE METASTASIS; METABOLISM; MUCUS; NEOPLASM; NOMENCLATURE; PATHOLOGY; PERITONEUM PSEUDOMYXOMA; PERITONEUM TUMOR; PREDICTIVE VALUE; TUMOR INVASION;

APPENDICEAL NEOPLASMS; BIOMARKERS, TUMOR; BIOPSY; CHECKLIST; CONSENSUS; DELPHI TECHNIQUE; HUMANS; LYMPHATIC METASTASIS; MUCINS; MUCUS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PSEUDOMYXOMA PERITONEI; TERMINOLOGY AS TOPIC;

EID: 84952628298     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000535     Document Type: Article

References (46)

1. Misdrajii J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003; 27: 1089-1103
2. Panarelli NC, Yantiss RK. Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med. 2011; 135: 1261-1268
3. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems and proposed classification. Adv Anat Pathol. 2005; 12: 291-311
4. Young RH. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol. 2004; 21: 134-150
5. Carr NJ, Finch J, Ilesley IC, et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol. 2012; 65: 919-923
6. Carr NJ, Sobin LH. Unusual tumors of the appendix and pseudomyxoma peritonei. Semin Diagn Pathol. 1996; 13: 314-325
7. Rosenberger LH, Stein LH, Witkiewicz AK, et al. Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature. J Gastrointest Surg. 2012; 16: 762-770
8. Agrawal AK, Bobiński P, Grzebieniak Z, et al. Pseudomyxoma peritonei originating from urachus-case report and review of the literature. Curr Oncol. 2014; 21: e155-e165
9. Daya D, Cheung AN, Khunamornpong S, et al. Secondary tumours. In: Kurman RJ, Carcangiu ML, Herrington CS, et al, eds. WHO Classification of Tumours of Female Reproductive Organs. Lyon: IARC; 2014: 100-101
10. Vang R, Gown AM, Zhao C, et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol. 2007; 31: 854-869
11. McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol. 2008; 32: 645-655
12. Stewart CJ, Ardakani NM, Doherty DA, et al. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary and a comparison with primary ovarian mucinous tumors. Int J Gynecol Pathol. 2014; 33: 1-10
13. Bradley RF, Stewart JH, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathological analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006; 30: 551-559
14. Davison JM, Choudry HA, Pingpank JF, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014; 27: 1521-1539
15. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med. 2010; 134: 864-870
16. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995; 19: 1390-1408
17. Carr NJ, Sobin LH. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumors of the Digestive System. Lyon: IARC; 2010: 122-125
18. Sugarbaker PH. Pseudomyxoma peritonei: a cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994; 219: 109-111
19. Guo AT, Li YM, Wei LX. Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors. World J Gastroenterol. 2012; 18: 3081-3088
20. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001; 92: 85-91
21. Bruin SC, Verwaal VJ, Vincent A, et al. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol. 2010; 17: 2330-2340
22. Shetty S, Natarajan B, Thomas P, et al. Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg. 2013; 79: 1171-1176
23. Moran B, Baratti D, Yan TD, et al. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008; 98: 277-282
24. Sirintrapun SJ, Blackham AU, Russell G, et al. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014; 45: 1597-1604
25. Li Y. Highlights from the 8th World Congress on Peritoneal Surface Malignancies. Cancer Biol Med. 2012; 9: 277-278
26. Kusamura S, Baratti D, Younan R, et al. The Delphi approach to attain consensus in methodology of local regional therapy for peritoneal surface malignancy. J Surg Oncol. 2008; 98: 217-219
27. Jones J, Hunter D. Consensus methods for medical and health services research. Brit Med J. 1995; 311: 376-380
28. Masud T, Blundell A, Gordon AL, et al. European undergraduate curriculum in geriatric medicine developed using an international modified Delphi technique. Age Ageing. 2014; 43: 695-702
29. Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010: 134-146
30. College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the appendix. October 2013. Available at: http: //www.cap.org/apps/cap.portal?-nfpb= true vwrPtlt-ActionOverride=%2Fportlets%2FcontentViewer %2Fshow&-windowLabel=cntvwrPtltvwrPtlt%7Baction-Form.contentReference%7D=committees%2Fcancer%2Fcancer- protocols%2Fprotocols-index.html&-state=maximized&-page Label=cntvwr. Accessed December 12, 2014
31. Sobin LH, Mk Gospodarowicz, Wittekind C. TNM Classification of Malignant Tumours. Oxford: Wiley-Blackwell; 2009: 86-90
32. González-Moreno S, Brun E, Sugarbaker PH. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2005; 12: 72-80
33. Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008; 32: 1429-1443
34. Pai RK, Beck AH, Norton JA, et al. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol. 2009; 33: 1425-1439
35. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012; 30: 2449-2456
36. Sugarbaker PH. New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome. Lancet Oncol. 2006; 7: 69-76
37. McDonald JR, ODwyer ST, Rout S, et al. Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg. 2012; 99: 987-992
38. Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010; 1: 651-661
39. Gibbons AV, Lin JE, Kim GW, et al. Intestinal GUCY2C prevents TGF-b secretion coordinating desmoplasia and hyperproliferation in colorectal cancer. Cancer Res. 2013; 73: 6654-6666
40. Humphrey PA, Dehner LP, Pfeifer JD, et al. The Washington Manual of Surgical Pathology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: 202
41. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix: a clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer. 1995; 75: 757-768
42. Yantiss RK, Shia J, Klimstra DS, et al. Prognostic significance of localized extra-Appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol. 2009; 33: 248-255
43. Pai RK, Hartman DJ, Gonzalo DH, et al. Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix. Hum Pathol. 2014; 45: 227-235
44. Bateman AC, Shepherd NA. UK guidance for the pathological reporting of serrated lesions of the colorectum. J Clin Pathol. 2015; 68: 585-591
45. Mohamed F, Gething S, Haiba M, et al. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol. 2004; 86: 10-15
46. Arnason T, Kamionek M, Yang M, et al. Significance of proximal margin involvement in low-grade appendiceal mucinous neoplasms. Arch Pathol Lab Med. 2015; 139: 518-521